China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025. According to the company, Mr. Wang stepped down due to other business engagements that require more of his time and has confirmed no disagreement with the board or matters needing shareholder attention. The board expressed gratitude for Mr. Wang’s contributions.

Simultaneously, the company appointed Ms. Bu Xue as Chief Executive Officer, effective the same date. Aged 36 and serving as an Executive Director since 1 April 2025, Ms. Bu holds a bachelor’s degree in Business Administration and has over a decade of experience in marketing and business development. She is qualified in accounting and taxation, with an annual remuneration of HK$96,000 for her roles as Executive Director and Chief Executive Officer.

Additionally, Mr. Wang ceased to be a member of the nomination committee of the board from 1 December 2025, and Independent Non-Executive Director Mr. Chau Wing Nam has been appointed to this role. The latest board composition comprises Professor Fei Phillip and Ms. Bu as Executive Directors, and three Independent Non-Executive Directors—including Mr. Chau—overseeing corporate governance.